Medicina Legal, Psiquiatría y Patología
Departamento
Jesús
Egido de los Ríos
Publicaciones en las que colabora con Jesús Egido de los Ríos (29)
2013
-
HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in atherosclerotic plaques and cultured monocytes
Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 33, Núm. 3, pp. 612-620
2011
-
TWEAKFn14 interaction enhances plasminogen activator inhibitor 1 and tissue factor expression in atherosclerotic plaques and in cultured vascular smooth muscle cells
Cardiovascular Research, Vol. 89, Núm. 1, pp. 225-233
2010
-
Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis
Cardiovascular Research, Vol. 86, Núm. 2, pp. 330-337
2009
-
Increased CD74 expression in human atherosclerotic plaques: Contribution to inflammatory responses in vascular cells
Cardiovascular Research, Vol. 83, Núm. 3, pp. 586-594
-
Leukotriene B4 enhances the activity of nuclear factor-κB pathway through BLT1 and BLT2 receptors in atherosclerosis
Cardiovascular Research, Vol. 81, Núm. 1, pp. 216-225
-
Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis
Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 29, Núm. 4, pp. 525-531
-
The CD163-expressing macrophages recognize and internalize TWEAK. Potential consequences in atherosclerosis
Atherosclerosis, Vol. 207, Núm. 1, pp. 103-110
2008
-
Chronic arthritis aggravates vascular lesions in rabbits with atherosclerosis: A novel model of atherosclerosis associated with chronic inflammation
Arthritis and Rheumatism, Vol. 58, Núm. 9, pp. 2723-2734
-
Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis
British Journal of Pharmacology, Vol. 154, Núm. 4, pp. 843-851
-
LDL induces parathyroid hormone-related protein expression in vascular smooth muscle cells: Modulation by simvastatin
Atherosclerosis, Vol. 198, Núm. 2, pp. 264-271
-
Treatment with amlodipine and atorvastatin has additive effect on blood and plaque inflammation in hypertensive patients with carotid atherosclerosis
Kidney International
2007
-
Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques
European Journal of Pharmacology, Vol. 562, Núm. 1-2, pp. 119-129
-
Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis
Journal of Pharmacology and Experimental Therapeutics, Vol. 320, Núm. 1, pp. 108-116
2006
-
Atorvastatin reduces the expression of prostaglandin E2 receptors in human carotid atherosclerotic plaques and monocytic cells: Potential implications for plaque stabilization
Journal of Cardiovascular Pharmacology, Vol. 47, Núm. 1, pp. 60-69
-
Fcγ receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice
Circulation Research, Vol. 99, Núm. 11, pp. 1188-1196
-
Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques: Modulation by atorvastatin
Stroke, Vol. 37, Núm. 8, pp. 2044-2053
-
Overexpression of COX-2, Prostaglandin E Synthase-1 and Prostaglandin E Receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis: Regulation by nuclear factor-κB
Atherosclerosis, Vol. 187, Núm. 1, pp. 139-149
-
Parthenolide modulates the NF-κB-mediated inflammatory responses in experimental atherosclerosis
Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 26, Núm. 8, pp. 1864-1870
2005
-
Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month
Stroke, Vol. 36, Núm. 8, pp. 1796-1800